Novavax Inc

NVV1

Company Profile

  • Business description

    Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

  • Contact

    700 Quince Orchard Road
    GaithersburgMD20878
    USA

    T: +1 240 268-2000

    E: [email protected]

    https://www.novavax.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,992

Stocks News & Analysis

stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,456.8015.00-0.18%
CAC 407,423.6715.030.20%
DAX 4020,271.33138.480.69%
Dow JONES (US)42,518.28221.160.52%
FTSE 1008,201.5422.65-0.28%
HKSE19,260.1740.390.21%
NASDAQ19,044.3943.71-0.23%
Nikkei 22538,444.5829.72-0.08%
NZX 50 Index12,943.5759.190.46%
S&P 5005,842.916.690.11%
S&P/ASX 2008,213.3017.70-0.22%
SSE Composite Index3,227.1213.82-0.43%

Market Movers